Synergy Pharma: 3Q Earnings Snapshot

Associated Press |

NEW YORK (AP) _ Synergy Pharmaceuticals Inc. (SGYP) on Thursday reported a loss of $34.5 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 14 cents.

The biopharmaceutical company posted revenue of $11.1 million in the period.

In the final minutes of trading on Thursday, the company's shares hit 45 cents. A year ago, they were trading at $2.93.

This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SGYP at

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Margaux Resources Ltd.

Margaux Resources Ltd is a Calgary based resource company. The Company is focused on its Jersey Emeral Tungsten-Zinc property located in the southeast portion of British Columbia.